Study of Occupational Risk Factors for Biliary and Pancreatic Cancers

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Intercommunal Creteil

About this trial

PANTOXBIL is a research project developed in the context of the increasing incidence of biliary tract and pancreatic cancers in France. Despite recent therapeutic advances, the prognosis of these cancers remains poor. Known risk factors do not fully explain the increase in incidence observed over recent decades. This suggests the possible role of emerging occupational and environmental risk factors, as reported in several epidemiological studies.

The PANTOXBIL study is based on the analysis of detailed curriculum laboris data (employment periods, occupations, tasks performed, and occupational exposures) collected during two multicenter phase II clinical trials, TEDOPAM and IMMUNOBIL, conducted between 2018 and 2021 in patients with pancreatic and biliary tract cancers.

An occupational exposure assessment was performed to calculate semi-quantitative cumulative exposure indices for each exposure or group of exposures for every participant. These indices will be compared with those of healthy controls from the CHOPPI cohort, initially designed to study occupational risk factors in COPD.

PANTOXBIL is a matched case-control study based on sex, age, and smoking status. The aim is to compare cumulative occupational exposure indices between cases and controls in order to generate new hypotheses regarding occupational risk factors for biliary tract and pancreatic cancers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients included in the TEDOPAM or IMMUNOBIL trials

Diagnosis of biliary tract or pancreatic cancer

Completed and exploitable curriculum laboris

Subjects from the CHOPPI cohort

Disqualifiers

Incomplete or non-exploitable occupational history

Refusal of data reuse

Trial population

Patients with pancreatic and biliary tract cancers included during two multicenter phase II clinical trials (cases) Control patients without pancreatic and biliary tract cancers from the CHOPPI cohort

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

210 Participants
are grouped into 2 trial groups
Group A: Patients with biliary tract or pancreatic cancers
Group B: Control patients

Trial outcomes

Primary outcomes

1

Compare the occupational exposure index to targeted toxicants

Compare the occupational exposure index to targeted toxicants, calculated from curriculum laboris, between patients with biliary-pancreatic cancers and controls without biliary-pancreatic cancers, in order to estimate for each toxicant an odds ratio and to identify occupational exposures potentially involved in the occurrence of these cancers

Time frame
Day 1

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Intercommunal Creteil

Lead sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group

Collaborator

This trial is not recruiting at the moment. You can still explore other options: